Michael Ehlers

Biogen has appointed Michael Ehlers as executive vice president of research and development. He will report to CEO George Scangos and will begin his tenure in late May. Ehlers joins Biogen from Pfizer where he served as group senior vice president for biotherapeutics research and development and CSO for the company's Neuroscience and Pain Research Unit. Prior to joining Pfizer in 2010, he was a professor of neurobiology and an investigator at the Howard Hughes Medical Institute at Duke University Medical Center.